Imperial College London’s Jadwiga A. Wedzicha, MD, discusses anti-alarmin trial results in COPD and where biologics may fit ...

Antimicrobial resistance in bronchiectasis and cystic fibrosis varied widely in a study spanning 11 centers on 3 continents.

Experts break down the GOLD 2026 COPD guidelines, highlighting updates to diagnosis criteria, Group E risk categories, and ...

More than 4 in 5 patients with hand eczema referred for patch testing at a Shanghai dermatology hospital reacted to at least ...

The Community Oncology Alliance said final 2027 Medicare payment rules address longstanding gaps between hospital and ...

An economic evaluation found nontargeted hepatitis C screening in emergency departments offered the greatest health benefit ...

Pooled data on 2698 patients tie rituximab maintenance after bendamustine-rituximab to better PFS and OS in mantle cell lymphoma.

The planned separation would keep Aetna, CVS Caremark, and Oak Street Health together and move roughly 9000 drugstores into a ...

In 299 patients, more involved compartments were linked to higher complication risk after one-stage resection; 14.4% had ...

At AMCP Nexus 2026, experts discusse how drug pricing policy, AI, and high-cost cell and gene therapies may shape managed ...

In part 2 of her AMCP Nexus 2026 interview, Jennifer S. Graff, PharmD, discusses improving patient experience data (PED) ...

A runner's death at the NYC marathon highlights how heat, dehydration, illness, drugs, and genetics can raise exertional ...